United States · FDA National Drug Code directory
NAPROXEN
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 76420-042_ead160e6-aba4-ca0a-e053-2a95a90ab964
- Product NDC
- 76420-042
- Form
- TABLET
- Composition / generic term
- NAPROXEN
- Labeler
- Asclemed USA, Inc.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20160706
- Source listing expiry
- 20261231
Source-listed ingredients
- NAPROXEN — 500 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 1 TABLET in 1 BOTTLE, PLASTIC (76420-042-01) · 76420-042-01
- 2 TABLET in 1 BOTTLE, PLASTIC (76420-042-02) · 76420-042-02
- 100 TABLET in 1 BOTTLE, PLASTIC (76420-042-10) · 76420-042-10
- 14 TABLET in 1 BOTTLE, PLASTIC (76420-042-14) · 76420-042-14
- 30 TABLET in 1 BOTTLE, PLASTIC (76420-042-30) · 76420-042-30
- 60 TABLET in 1 BOTTLE, PLASTIC (76420-042-60) · 76420-042-60
- 90 TABLET in 1 BOTTLE, PLASTIC (76420-042-90) · 76420-042-90
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →